# Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19

> **NCT04434131** · PHASE2 · COMPLETED · sponsor: **University of New Mexico** · enrollment: 12 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Convalescent Plasma

## Key facts

- **NCT ID:** NCT04434131
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-28
- **Primary completion:** 2020-07-31
- **Final completion:** 2021-03-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04434131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04434131, "Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT04434131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*